Evidence map›Paper›PMID 25568205›Full record

ArticleJournal of virology2015

Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.

Marie Lambelé, Herwig Koppensteiner, Menelaos Symeonides, Nathan H Roy, Jany Chan, Michael Schindler, Markus Thali

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.Microbiology and molecular biology reviews : MMBR · 2016
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Tetraspanins: Host Factors in Viral Infections.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marie LambeléDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Herwig KoppensteinerInstitute of Virology, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany.
Menelaos SymeonidesDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, Vermont, USA.
Nathan H RoyDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, Vermont, USA.
Jany ChanDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Michael SchindlerInstitute of Virology, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany Institute of Medical Virology and Epidemiology of Viral Diseases, University Clinic Tübingen, Tübingen, Germany.
Markus ThaliDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA Graduate Program in Cell and Molecular Biology, University of Vermont, Burlington, Vermont, USA College of Medicine and CALS, University of Vermont, Burlington, Vermont, USA markus.thali@uvm.edu.
University of Vermont · USHelmholtz Zentrum München · DE

Funding

Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Molecular regulation of HIV-1 assembly, release and cell-to-cell transmissionR01AI080302 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI THALI, MARKUS · 2009 to 2013
$1.9M
NIAID NIH HHS R01 AI080302NIAID NIH HHS T32 AI055402NIAID NIH HHS T32 AI055402-06A1
6 · The paper itself

Abstract

unlabelledTetraspanins constitute a family of cellular proteins that organize various membrane-based processes. Several members of this family, including CD81, are actively recruited by HIV-1 Gag to viral assembly and release sites. Despite their enrichment at viral exit sites, the overall levels of tetraspanins are decreased in HIV-1-infected cells. Here, we identify Vpu as the main viral determinant for tetraspanin downregulation. We also show that reduction of CD81 levels by Vpu is not a by-product of CD4 or BST-2/tetherin elimination from the surfaces of infected cells and likely occurs through an interaction between Vpu and CD81. Finally, we document that Vpu-mediated downregulation of CD81 from the surfaces of infected T cells can contribute to preserving the infectiousness of viral particles, thus revealing a novel Vpu function that promotes virus propagation by modulating the host cell environment. IMPORTANCE: The HIV-1 accessory protein Vpu has previously been shown to downregulate various host cell factors, thus helping the virus to overcome restriction barriers, evade immune attack, and maintain the infectivity of viral particles. Our study identifies tetraspanins as an additional group of host factors whose expression at the surfaces of infected cells is lowered by Vpu. While the downregulation of these integral membrane proteins, including CD81 and CD82, likely affects more than one function of HIV-1-infected cells, we document that Vpu-mediated lowering of CD81 levels in viral particles can be critical to maintaining their infectiousness.

Indexed as

Down-RegulationHIV-1HIV InfectionsHost-Pathogen InteractionsHuman Immunodeficiency Virus ProteinsHumansProtein BindingTetraspanin 28Viral Regulatory and Accessory ProteinsViroporin ProteinsCD81 protein, humanHuman Immunodeficiency Virus ProteinsTetraspanin 28Viral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1

Identifiers

PMID25568205
PMCPMC4337535
OpenAlexW1996636273

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.